188 related articles for article (PubMed ID: 20005901)
1. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.
Hodrea J; Demény MA; Majai G; Sarang Z; Korponay-Szabó IR; Fésüs L
Immunol Lett; 2010 May; 130(1-2):74-81. PubMed ID: 20005901
[TBL] [Abstract][Full Text] [Related]
2. The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.
Stamnaes J; Fleckenstein B; Lund-Johansen F; Sollid LM
Scand J Immunol; 2008 Nov; 68(5):534-42. PubMed ID: 18803608
[TBL] [Abstract][Full Text] [Related]
3. Surface expression of transglutaminase 2 by dendritic cells and its potential role for uptake and presentation of gluten peptides to T cells.
Ráki M; Schjetne KW; Stamnaes J; Molberg Ø; Jahnsen FL; Issekutz TB; Bogen B; Sollid LM
Scand J Immunol; 2007 Mar; 65(3):213-20. PubMed ID: 17309775
[TBL] [Abstract][Full Text] [Related]
4. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
5. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
6. Transglutaminase 2 on the surface of dendritic cells is proposed to be involved in dendritic cell-T cell interaction.
Kim JH; Jeong EM; Jeong YJ; Lee WJ; Kang JS; Kim IG; Hwang YI
Cell Immunol; 2014; 289(1-2):55-62. PubMed ID: 24727157
[TBL] [Abstract][Full Text] [Related]
7. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 limits murine peritoneal acute gout-like inflammation by regulating macrophage clearance of apoptotic neutrophils.
Rose DM; Sydlaske AD; Agha-Babakhani A; Johnson K; Terkeltaub R
Arthritis Rheum; 2006 Oct; 54(10):3363-71. PubMed ID: 17009310
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.
Tatsukawa H; Kojima S
Cell Biol Int; 2010 Feb; 34(3):325-34. PubMed ID: 20192918
[TBL] [Abstract][Full Text] [Related]
10. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
11. Transglutaminase 2 silencing reduced the beta-amyloid-effects on the activation of human THP-1 cells.
Currò M; Ferlazzo N; Condello S; Caccamo D; Ientile R
Amino Acids; 2010 Nov; 39(5):1427-33. PubMed ID: 20437185
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase 2 in celiac disease: minireview article.
Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
[TBL] [Abstract][Full Text] [Related]
14. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
Forsprecher J; Wang Z; Nelea V; Kaartinen MT
Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
[TBL] [Abstract][Full Text] [Related]
15. Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures.
Nakano Y; Forsprecher J; Kaartinen MT
J Cell Physiol; 2010 Apr; 223(1):260-9. PubMed ID: 20049897
[TBL] [Abstract][Full Text] [Related]
16. Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
Király R; Csosz E; Kurtán T; Antus S; Szigeti K; Simon-Vecsei Z; Korponay-Szabó IR; Keresztessy Z; Fésüs L
FEBS J; 2009 Dec; 276(23):7083-96. PubMed ID: 19878304
[TBL] [Abstract][Full Text] [Related]
17. Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.
Feriotto G; Calza R; Bergamini CM; Griffin M; Wang Z; Beninati S; Ferretti V; Marzola E; Guerrini R; Pagnoni A; Cavazzini A; Casciano F; Mischiati C
Amino Acids; 2017 Mar; 49(3):551-565. PubMed ID: 27699491
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
Mehta K; Fok J; Miller FR; Koul D; Sahin AA
Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
[TBL] [Abstract][Full Text] [Related]
19. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
Park D; Choi SS; Ha KS
Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
